NuCalm
NuCalm Channels

NuCalm Confidential


Invest in Your NuCalm Future

Whether you have been with us for years, or are new to the NuCalm family, you have experienced the profound impact of NuCalm. Over the past four years we transitioned from an FDA CLASS III medical device to a mobile app, mapped the entire frequency range of the human brain, grew from one product (Rescue) to 8 products on our mobile app, launched the MASTERMIND VAULT, increased our annual retention to over 54%, created a 7-day free trial, and lowered our entry price by more than 95%. This labor of love and commitment to managing the world's stress and improving sleep has taken years of engineering, testing, validation, and continuous improvement.

Now it's time to accelerate our growth and get millions of people to try NuCalm. Whether you are a seasoned investor, or simply someone who sees the value in a revolutionary technology that is changing people's lives, we are inviting you to become a part of the NuCalm mission in an even deeper way, with an exclusive private equity opportunity. This is a rare and exclusive opportunity to invest in a private company that is growing and effectively addressing real problems, with proven solutions

Where we have been

  • Invented the world's first and only patented technology, clinically proven to solve stress and improve sleep without drugs
  • Served doctors, pilots, elite military operators, the FBI, cancer patients, and professional athletes with a $6,000 FDA Class III medical device from 2009 - 2021
  • Used in over 2,700,000 surgical procedures replacing general anesthesia with over a 95% patient satisfaction rate
  • Successfully transitioned from an FDA Class III medical device to a consumer-focused mobile app
  • Mapped the entire human brain wave frequency range (delta > theta > alpha > beta > gamma)
  • Expanded from 1 product (Rescue) to 8 products (Rescue, DeepestSleep, DeepestSleep+, PowerNap, Ignite, Priming, Focus, FlowState) in the past few years
  • Lowered the price from a $6,000, one-time fee, to a monthly subscription for as low as 50 cents per day, making NuCalm accessible to the masses

Where we are

  • Built a scalable infrastructure and business model
  • Serving customers across 100 countries with our mobile app
  • Have high gross margins
  • Have 54% annual customer retention rates (industry average is 3.7%)
  • Converting over 60% of free trial users to paid subscribers

Where we are going

  • Creating a new mobile app with AI integration and voice analysis to show the quantified impact of NuCalm
  • Launching a free app featuring some Rescue and DeepSleep programs for global expansion and to serve as a feeder to the NuCalm app
  • Growing our subscriber base to 2M
  • Positioning the enterprise to exit at $1B - $2B via acquisition or IPO

Minimum Investment: $50,000

CONFIDENTIAL Investment Presentation

Play

Materials for Review

CONFIDENTIAL NuCalm Investment Deck
CONFIDENTIAL NuCalm Convertible Promissory Note Terms

PDF Passwords: NuCalmGlobal (* Case Sensitive with a capital 'N', capital 'C', and a capital 'G'.)

Please do not distribute without prior authorization